Thursday, May 03, 2007 11:17:29 PM
Wink wink nudge nudge ;)
Two of the posters to be presented will demonstrate the feasibility of delivering bioactive proteins from SurModics' sustained delivery systems. Currently, the leading drug for treatment of age related macular degeneration (AMD) is a protein therapeutic that requires repeat intraocular injections
Two of the posters to be presented will demonstrate the feasibility of delivering bioactive proteins from SurModics' sustained delivery systems. Currently, the leading drug for treatment of age related macular degeneration (AMD) is a protein therapeutic that requires repeat intraocular injections
Recent SRDX News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/21/2025 05:15:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:16:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:15:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:14:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:13:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:11:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:10:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:08:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:06:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:04:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:03:24 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 11/19/2025 09:48:05 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 11/19/2025 09:32:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/19/2025 09:30:15 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 11/19/2025 02:47:33 PM
